Today’s MICT filing of a resale registration statement amendment relates to the registration of a portion of the restricted shares in issue and does not reflect a new issuance of stock

MONTVALE, N.J., Jan. 29, 2021 (GLOBE NEWSWIRE) -- Today MICT, Inc. (Nasdaq: MICT) (“MICT” or the “Company”) filed an amendment to the resale registration statement filing made on Friday, December 18, 2020. The Company wishes to clarify the purpose of the filing of the resale registration statement and this amendment. The filings were not for a new issuance of shares but were made to register a portion of the Company's currently outstanding restricted shares from certain of its holders.

About MICT         MICT, Inc. (NasdaqCM: MICT) operates through its subsidiaries, GFH Intermediate Holdings Ltd. (“GFHI”) and Micronet Ltd. (“Micronet”). GFHI’s versatile proprietary trading technology platform is designed to serve a large number of high growth sectors in the global fintech space. Primary areas of focus include online brokerage for equities trading and wealth management services and sales of insurance products in several high-growth foreign markets, including Asia, where GFHI owns a substantial database of users. Micronet operates in the growing telematics and commercial Mobile Resource Management market, mainly in the United States and Europe. Micronet designs, develops, manufactures, and sells mobile computing solutions that provide fleet operators and field workforces with computing solutions in challenging work environments.

Forward-Looking Statements        Litigation Reform Act of 1995 and other U.S. Federal securities laws. These forward-looking statements include, but are not limited to, statements related to revenue targets, the growth of the Chinese Insurance market and other statements that are not historical facts. Such forward-looking statements and their implications involve known and unknown risks, uncertainties and other factors that may cause actual results or performance to differ materially from those projected. The forward-looking statements contained in this press release are subject to other risks and uncertainties, including those discussed in the "Risk Factors" section and elsewhere in the Company's annual report on Form 10-K for the year ended December 31, 2019 and in subsequent filings with the Securities and Exchange Commission. Except as otherwise required by law, the Company is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Contacts: [email protected] (201) 225-0190

You May Also Be Interested In

• CIDARA Therapeutics ALERT: Bragar Eagel & Squire, P.C. is Investigating Cidara Therapeutics, Inc. on Behalf of Cidara Therapeutics Stockholders and Encourages Investors to Contact the Firm
• YPF SA reports
• ROSEN, A LEADING LAW FIRM, Encourages VinFast Auto Ltd. f/k/a Black Spade Acquisition Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VFS